Pfizer Inc. (NYSE: PFE) and competitor Allergan Plc. (NYSE: AGN) announced the largest healthcare deal in history today (Monday).
The combination is a very bullish catalyst for the PFE stock price.
By Diane Alter, Contributing Writer, Money Morning -
Pfizer Inc. (NYSE: PFE) and competitor Allergan Plc. (NYSE: AGN) announced the largest healthcare deal in history today (Monday).
The combination is a very bullish catalyst for the PFE stock price.
By Diane Alter, Contributing Writer, Money Morning -
Pfizer Inc. (NYSE: PFE) and competitor Allergan Plc. (NYSE: AGN) announced the largest healthcare deal in history today (Monday).
The combination is a very bullish catalyst for the PFE stock price.
By Diane Alter, Contributing Writer, Money Morning -
The Pfizer stock price is up 0.5% today as the U.S. drug giant remains in advanced stages to buy Allergan Plc. (NYSE: AGN).
Pfizer Inc. (NYSE: PFE) is pushing forward with the deal despite the best wishes of the U.S. Treasury, which is trying to curb such mergers.
By Kyle Anderson, Associate Editor, Money Morning • @KyleAndersonMM -
The Pfizer earnings and Merck earnings reports were both released this morning (Tuesday), and investors are acting differently to these major pharmaceutical stocks.
Pfizer Inc. (NYSE: PFE) stock was up 1.3% in early trading despite missing earnings per share estimates. Merck shares were down 2% despite topping estimates.
Here's why the stocks are behaving so differently...